Ces radiol. 2014, 68(1):64-68

Brain lymphomas, imaging characteristicOriginal article

Radek Tupý1, Jiří Ferda1, Jan Kastner1, Hynek Mírka1, Samuel Vokurka2
1 Klinika zobrazovacích metod LF UK a FN, Plzeň
2 Hematologicko-onkologické oddělení LF UK a FN, Plzeň

Aim: To revise and verify imaging methods characteristics of clinically significant and relatively rare brain lymphomas.

Methods: Retrospective analysis of CT and MR imaging methods results in patients with brain lymphoma diagnosed in 2001-2013 at our university hospital.

Results: 30 patients with median age of 60 (24-82) years were analysed. CT were performed in 25/30, MR in 24/30 patients, and 20 CT and 21 MR were available for retrospective revision. The primary and isolated brain lymphoma (histologically non-hodgkin Difuse Large B-cell Lymphoma) was defined in 22/30 (73%) patients, in the others the systemic Non-Hodgkin lymphoma (4/30) or isolated relapse (4/30) were present. Median number of NHL lesions was one (1-8), in one case there were tens of lesions present. Median diameter of the lesions was 28 × 30 × 29 (11 × 16 × 20 to 85 × 76 × 65) mm. The fundamental finding in brain lymphoma MR imaging was lesion with marked contrast enhancement, predominantly homogenous, diffusion restriction and large collateral oedema with minimal expantion. Only in 2 out of 16 patients with lumbar puncture, lymphoma presence in fluid was detected.

Conclusion: When specifying brain focal lesions on MR, it is necessary to consider lymphoma etiology and to elect imaging protocols with contrast agents and diffusion weighted sequence. Imaging methods and biopsy should be performed prior to start of corticosteroid therapy, as this modifies the characteristics of the lesions.

Keywords: lymphoma, brain, magnetic resonance imaging

Accepted: January 20, 2014; Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tupý R, Ferda J, Kastner J, Mírka H, Vokurka S. Brain lymphomas, imaging characteristic. Ces radiol. 2014;68(1):64-68.
Download citation

References

  1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4. vydání. Lyon: International Agency for Research on Cancer (IARC) 2008.
  2. www.lymphoma.cz/intro.php
  3. Belada D, Trněný M, et al. Diagnostické a léčebné postupy u nemocných s maligními lymfomy, 7. vydání. Hradec Králové: HK CREDIT s.r.o. 2013.
  4. Pánková J, Benešová E, Klener P, et al. Primární lymfom centrální nervové soustavy. Klinická onkologie 1998; 11(4): 112-115.
  5. Boudová L, Fakan F, Škůci I, et al. Lymfomy centrálního nervového systému. Klinickopatologická studie 70 případů. Abstrakt 004. In: Sborník abstrakt. XII. Jihočeské onkologické dny. Český Krumlov 13.-15. října 2005.
  6. Vokurka S, Tupý R, Boudová L, et al. Klinické, histopatologické a zobrazovací charakteristiky non-hodgkinských lymfomů u pacientů s postižením mozku. Klinická onkologie 2013; 26(5): 348-353. Go to original source... Go to PubMed...
  7. Schorb E, Kasenda B, Atta J, et al. Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation. Haematologica 2013; 98: 765-770. Go to original source... Go to PubMed...
  8. Rubenstein JL, Hsi ED, Johnson JL, et al. Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202). J Clin Oncol 2013; 31: 3061-3068. Go to original source... Go to PubMed...
  9. Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011; 32(6): 984-992. Go to original source... Go to PubMed...
  10. Johnson BA, Fram EK, Johnson PC, Jacobowitz R. The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol 1997; 18(3): 563-572.
  11. Valles FE, Perez-Valles CL, Regalado S, Barajas RF, Rubenstein JL, Cha S. Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma. AJNR Am J Neuroradiol 2013; 34(1): 35-40. Go to original source... Go to PubMed...
  12. Yap KK, Sutherland T, Liew E, Tartaglia CJ, Pang M, Trost N. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay. J Med Imaging Radiat Oncol 2012; 56(2): 179-186. Go to original source... Go to PubMed...
  13. Schramm P, Xyda A, Klotz E, Tronnier V, Knauth M, Hartmann M. Dynamic CT perfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 2010; 20(10): 2482-2490. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.